Charles Russell Speechlys acts for CareTech Holdings PLC
The Charles Russell Speechlys Corporate team has recently advised CareTech Holdings PLC (CareTech), a leading provider of specialist social care services in the UK, on its conditional £21m placing of new shares on the AIM market of the London Stock Exchange.
CareTech’s anticipated market capitalisation following the placing will be approximately £130m.
The net proceeds of the placing will be used to support organic growth, to fund bolt-on acquisitions and property purchases and to strengthen the company’s balance sheet.
Completion of the placing is conditional on approval of the requisite shareholder authorities at CareTech’s annual general meeting on 3 March 2015 and admission of the placing shares to trading on AIM is expected to take place on 10 March 2015.
The Charles Russell Speechlys team was led by Corporate Partner Michael Lingens with assistance from Corporate Associate Chris Manning.
News & Insights
Government provides welcome clarity for EMI option holders who have been furloughed
The proposed amendments will provide some clarity and address concerns regarding the consequences of furloughing EMI option holders.
Charles Russell Speechlys advises Transense Technologies Plc on iTrack technology transaction with Bridgestone Corporation
Transense Technologies Plc, the provider of sensor systems for the industrial, mining and transportation markets.
Charles Russell Speechlys advises Kreos and SVB on $70m private placement for AIM listed Mereo BioPharma Group plc
Mereo BioPharma is a clinical stage UK-based biopharmaceutical company listed on the AIM market of the LSE.